Mr
Paul
Andrew
School of Medicine and Population Health
Senior Skin Research Technician
Paul.Andrew@sheffield.ac.uk
+44 114 215 9539
+44 114 215 9539
The Medical School
Full contact details
Mr Paul Andrew
The Medical School
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
- Publications
-
Show: Featured publications All publications
Featured publications
This person does not have any publications available.
All publications
Journal articles
- . Experimental Dermatology, 34(12).
- . British Journal of Dermatology, 193(4), 729-740.
- . JEADV Clinical Practice, 4(1), 103-116.
- . Dermatology and Therapy, 14(2), 391-408.
- . Clinical and Experimental Dermatology, 47(6), 1154-1164.
- . British Journal of Dermatology, 186(5), 875-886.
- . Dermatology and Therapy, 11(6), 2249-2252.
- . Dermatology and Therapy, 10(5), 1031-1041.
- . British Journal of Dermatology.
Conference proceedings
- EFFECTS OF EMOLLIENT CREAMS ON THE SKIN BARRIER OF PATIENTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 102 (pp 35-36)
- A RANDOMIZED CONTROLLED PHASE 2 TRIAL COMPARING THE EFFECTS OF CRISABOROLE 2% OINTMENT TO BETAMETHASONE VALERATE 0.1% CREAM ON SKIN STRUCTURE IN PARTICIPANTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 102 (pp 56-57)
- LOWERING SKIN SURFACE PH WITH A TOPICAL ZINC LACTOBIONATE PREPARATION CONTAINING PHYSIOLOGIC LIPIDS IMPROVES SKIN BARRIER STRUCTURE AND FUNCTION IN ADULTS WITH ATOPIC DERMATITIS. ACTA DERMATO-VENEREOLOGICA, Vol. 101 (pp 51-51)
- An investigation of the skin barrier restoring effects of a cream containing ceramides in a multivesicular emulsion in people with dry, eczema-prone, skin: The RESTORE study phase 2. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, Vol. 83(6) (pp AB71-AB71)
Posters
- P24 Emollient use and effects on cutaneous allergen reactions: a preliminary study.
- 16818 An investigation of the skin barrier restoring effects of a cream containing ceramides in a multivesicular emulsion in people with dry, eczema-prone, skin: The RESTORE study phase 2.